Selecting Comparable Transaction Multiples for a Private Company

Selecting comparable transaction multiples for a private company requires matching the subject business to a representative set of sold transactions by industry, scale, and timing—then understanding why each comparable’s multiple justifies use or adjustment. Done rigorously, this approach avoids the distortions of a single outlier deal while anchoring value in market-tested transactions.

Finding and sourcing comparable transactions

The first step is identifying transactions in your company’s industry and region over a defensible time period. Standard databases—FactSet, Refinitiv, S&P Capital IQ, and Pitchbook—catalog deal announcements, closings, and disclosed prices. Each database has blind spots and coverage inconsistencies, particularly in lower middle-market deals ($25M–$500M), so cross-checking two or three sources is standard practice.

For private-equity-backed exits and smaller transactions, proprietary deal lists from investment banks and industry groups fill gaps. An analyst covering a niche sector may build a manual database of known transactions over years, often more reliable than off-the-shelf sources for specialized sub-segments.

The definition of “industry” matters enormously. Matching too broadly (e.g., all “software”) dilutes signal; matching too narrowly (e.g., “SaaS for dental practices”) may yield no comps. The discipline is to start broad and tighten iteratively, assessing whether each sub-segment has material differences in return on equity, cash-conversion cycles, or buyer interest. A rule of thumb: if every transaction in your narrowed set sold to the same buyer type or financial buyer, you’ve likely over-segmented.

Filtering by size, timing, and deal structure

Once you have a candidate list, apply mechanical filters:

Revenue / EBITDA magnitude: Does each comparable have publicly disclosed or announced financial metrics close to the subject company’s scale? A transaction of a $200M revenue business may have a different EBITDA multiple than a $2M business, even in the same niche, due to operational leverage and buyer interest. Include a range—say $50M–$500M in revenue—and note where the subject falls within it.

Timing: Transactions from five years ago may reflect different market conditions, exit multiples, and buyer appetite than those from the past 12 months. In bull markets (2021) and bear cycles (2023), multiples diverge sharply. Standard practice is to use transactions from the past 3–5 years, weighting more recent deals more heavily. If your valuation date falls in a market downturn, extend the window but adjust for cyclicality; never anchor solely to deals from a peak or trough.

Deal type: Distinguish between strategic acquisitions (where a buyer may generate synergies) and financial buyer acquisitions (private equity leveraged buyouts or growth equity). A strategic buyer may pay a premium for a competitor’s customer base; a financial buyer relies on standalone cash flow. If your subject company is likely a financial-buyer target, exclude strategic acquisitions at inflated multiples—or adjust them downward. If the subject has unique synergy value, include strategic deals but mark the premium separately.

Exclude deals that were distressed, carved out as non-core, or minority stakes acquired at deep discounts. These outliers distort the multiple set.

The problem of comparable size variation

A consistent challenge: should a $500M EBITDA business trade at the same multiple as a $50M EBITDA peer? Empirically, larger, more profitable companies often command higher multiples due to lower execution risk, easier financing, and deeper management. This is why many analysts apply a “size adjustment”—modestly raising or lowering multiples based on subject company size relative to the comp median.

One approach: plot median multiple against deal size for your comp set and estimate the slope. If the median multiple rises 0.1x for every doubling of EBITDA, apply that slope to adjust the subject’s appropriate multiple upward or downward. This is rough but grounded in your actual data rather than dogma.

Alternatively, if your subject is a clear outlier in size (e.g., vastly smaller), disclose this limitation and acknowledge wider valuation range. Forcing a tiny business into a multiple built for mid-market deals is a common source of valuation error.

Adjusting for profitability and growth

Beyond mechanics, use comparables to understand what the market pays for profitability and growth. A comparable company with 50% EBITDA margins likely traded at a higher multiple than one with 15% margins, all else equal. When applying the multiple to your subject, adjust if margins differ materially.

Similarly, if your comparables include some growing 30% annually and others in mature 3% growth, the median multiple is a compromise. If your subject is high-growth, consider the sub-set of high-growth comparables; if it’s mature, use the mature sub-set. This is more honest than applying the aggregate median and pretending the subject is “average.”

Dealing with leverage and working capital adjustments

Published multiples sometimes reflect the leverage the buyer took on. A deal announced at a 7x EBITDA multiple may include 4x of debt, meaning the equity value was much lower. If you’re valuing on an all-in (enterprise value) basis, use EV/EBITDA multiples stripped of leverage assumptions. If some comps have disclosed buyer leverage and others have not, either standardize to an unlevered basis or explicitly flag the mixture.

Working capital dynamics matter too. A business with high seasonality or a long sales cycle may have different net working capital at close than an industry peer. If a comparable was acquired at a seasonal peak (high receivables and inventory), its disclosed enterprise value may not reflect the true buyer’s entry price. Adjustments here are rough, but directionally important.

Outliers and weighting

Once you have a filtered set of 6–15 transactions, calculate the median, mean, and quartiles of the key multiples (EV/Revenue, EV/EBITDA, EV/EBIT). Outliers—deals trading at 2x or 15x when peers are at 5x–7x—often have stories. Did the outlier have a unique technology, buyer synergy, or distressed sale? Understanding why it diverged helps you decide whether to include, weight it down, or exclude it.

Best practice is to weight each transaction equally unless you have explicit reasons to do otherwise (e.g., more recent deals, better size match). Equal weighting is transparent and defensible in a report; arbitrary weightings invite criticism.

Final multiple selection and sensitivity

After filtering, adjusting, and analyzing, select a multiple range rather than a point estimate. For instance: “Based on 10 recent comparable transactions, the median EV/EBITDA multiple for similar-sized, profitable software companies is 7.5x, with a range of 6.5x–8.5x.” Apply that range to your subject’s EBITDA to generate a valuation band. Use the low end for a conservative scenario, the mid-range for base case, and the high end for upside.

Sensitivity analysis is essential. Show how valuation changes if you shift the multiple by ±0.5x or ±10%. This reveals which assumptions are make-or-break and builds credibility by acknowledging uncertainty.

Common pitfalls

• Survivorship bias: Including only successful exits. Failed companies and long-holding-period deals rarely make it into public databases, skewing multiples upward.
• Buyer-induced inflation: Confusing a strategic buyer’s synergy-inflated price with intrinsic value. Adjust or exclude.
• Temporal clustering: Leaning too heavily on a narrow window (e.g., only 2021–2022 deals) and extrapolating a bubble as the market norm.
• Over-precision: Declaring “the multiple is 7.34x” when your comp set ranges from 5.8x to 9.2x. Ranges are more honest.

See also